Cancer statistics, 2018

Published on Jan 1, 2018in CA: A Cancer Journal for Clinicians292.278
· DOI :10.3322/CAAC.21442
Rebecca L. Siegel67
Estimated H-index: 67
(ACS: American Cancer Society),
Kimberly D. Miller28
Estimated H-index: 28
(ACS: American Cancer Society),
Ahmedin Jemal139
Estimated H-index: 139
(ACS: American Cancer Society)
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the National Center for Health Statistics. In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2005-2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006-2015) declined by about 1.5% annually in both men and women. The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Of the 10 leading causes of death, only cancer declined from 2014 to 2015. In 2015, the cancer death rate was 14% higher in non-Hispanic blacks (NHBs) than non-Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13-1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29-1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06-1.09) and varied substantially by state. For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16-3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56-2.02), Kansas (DRR, 1.51; 95% CI, 1.25-1.81), Louisiana (DRR, 1.49; 95% CI, 1.38-1.60), Illinois (DRR, 1.48; 95% CI, 1.39-1.57), and California (DRR, 1.45; 95% CI, 1.38-1.54). Larger racial inequalities in young and middle-aged adults probably partly reflect less access to high-quality health care. CA Cancer J Clin 2018;68:7-30. © 2018 American Cancer Society.
📖 Papers frequently viewed together
5,552 Citations
1 Author (David P. Bartel)
27.2k Citations
3,248 Citations
#1Carol DeSantis (ACS: American Cancer Society)H-Index: 32
#2Jiemin Ma (ACS: American Cancer Society)H-Index: 25
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 5 authors...
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 252,710 new cases of invasive breast cancer and 40,610 breast cancer deaths are expected to occur among US women in 2017. From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non-Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% pe...
825 CitationsSource
#1Meg Watson (CDC: Centers for Disease Control and Prevention)H-Index: 31
#2Ashwini SomanH-Index: 11
Last. Mona Saraiya (CDC: Centers for Disease Control and Prevention)H-Index: 62
view all 11 authors...
Abstract Surveillance of cervical intraepithelial neoplasia grade III (CIN III) and adenocarcinoma in situ (AIS) is important for determining the burden of a preventable disease, identifying effects of vaccination on future diagnoses, and developing targeted programs. We analyzed population-based rates of high-grade cervical cancer precursor lesions using data from four central cancer registries (diagnosis years 2009–2012 from Louisiana, Kentucky, Michigan, and diagnosis years 2011–2012 from Los...
18 CitationsSource
#1Zubair W. BalochH-Index: 71
#2R. Mack HarrellH-Index: 9
Last. Jeffrey R. GarberH-Index: 22
view all 5 authors...
ABSTRACT This commentary summarizes the history and reclassification of noninvasive follicular thyroid neoplasm with papillary-like nuclei (NIFTP). It reviews the salient histopathologic features that are based on immunohistochemical and molecular profiles and serve as inclusion and exclusion criteria. The authors also provide their own point of view regarding the practical issues and possible concerns that may be raised by both clinicians and patients based on the diagnosis of NIFTP. Abbreviati...
26 CitationsSource
#1Ahmedin Jemal (ACS: American Cancer Society)H-Index: 5
#1Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
Last. Hannah K. Weir (CDC: Centers for Disease Control and Prevention)H-Index: 33
view all 16 authors...
Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate to provide annual updates on cancer occurrence and trends in the United States. This Annual Report highlights survival rates. Data were from the CDC- and NCI-funded population-based cancer registry programs and compiled by NAACCR. Trends in age-standardized incidence and death...
618 CitationsSource
#1Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
#2Stacey A. Fedewa (ACS: American Cancer Society)H-Index: 43
257 CitationsSource
: The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents routinely receive tetanus, diphtheria, and acellular pertussis vaccine (Tdap), meningococcal conjugate vaccine (MenACWY), and human papillomavirus (HPV) vaccine (1) at age 11-12 years. ACIP also recommends catch-up vaccination with hepatitis B vaccine, measles, mumps, and rubella (MMR) vaccine, and varicella vaccine for adolescents who are not up to date with childhood vaccinations. ACIP recommends a booster do...
262 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 28
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
This study uses National Center for Health Statistics data to analyze colorectal cancer mortality rates among US adults aged 20 to 54 years by race from 1970 through 2014.
125 CitationsSource
#1Ann Goding Sauer (ACS: American Cancer Society)H-Index: 22
#2Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
Last. Stacey A. Fedewa (ACS: American Cancer Society)H-Index: 43
view all 4 authors...
Much of the suffering and death from cancer could be prevented by more systematic efforts to reduce tobacco use and obesity, improve diet, and increase physical activity and use of established vaccines and screening tests. Monitoring the prevalence of cancer risk factors and preventive tests helps guide cancer prevention and early detection efforts. We provide an updated review, using data through 2015, of the prevalence of major risk factors, cancer screening, and vaccination for U.S. adults an...
43 CitationsSource
#1Stacey A. Fedewa (ACS: American Cancer Society)H-Index: 43
#2Elizabeth Ward (ACS: American Cancer Society)H-Index: 86
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 4 authors...
22 CitationsSource
#1Benjamin D. Sommers (Harvard University)H-Index: 52
#2Atul A. Gawande (Harvard University)H-Index: 86
Last. Katherine Baicker (Harvard University)H-Index: 44
view all 3 authors...
The authors report their analysis of the highest quality research over the past decade examining the effects of health insurance on health and conclude that insurance coverage increases access to care and improves health outcomes.
185 CitationsSource
Cited By10094
#1Ximena MimicaH-Index: 4
#2Marc CohenH-Index: 73
Abstract null null Head and neck cancers are the sixth most common group of malignancies worldwide. In the United States, the estimated incidence is 65,000 new cases per year. Head and neck cancers can arise in the oral cavity, nasopharynx, hypopharynx, oropharynx, nasal cavity and paranasal sinuses, larynx, and salivary glands. Multiple histologies can be found in these sites, but more than 90% are squamous cell carcinomas (SCC). SCC is associated with aggressive behavior and high incidence of ...
#1Juanjuan Yong (SYSU: Sun Yat-sen University)
#2Liyun Huang (SYSU: Sun Yat-sen University)
Last. Lin Wang (SYSU: Sun Yat-sen University)
view all 6 authors...
Stabilin-2 has been found to regulate the progression of cancer. It was not fully understood whether it shows some roles in non-small-cell lung cancer (NSCLC). We used the immunohistochemical staining to evaluate Stabilin-2 protein expression in formalin-fixed paraffin-embedded tissue of NSCLC patients' primary lesion. And we carried out χ2 test to detect relationships between Stabilin-2 expression and various clinical factors. Besides, the survival difference between patients with high and low S...
#1Mohamed Rahamathulla (King Khalid University)H-Index: 4
#2Saad M. Alsahhrani (Salman bin Abdulaziz University)
Last. Faiyaz Shakeel (KSU: King Saud University)H-Index: 34
view all 0 authors...
Abstract null null The main purpose of this study was to develop a novel gastro-retentive drug delivery system via effervescent technique for the treatment of breast cancer. Neratinib (NTB) is a novel anticancer drug, poorly soluble at higher pH, was been used as a model drug and an attempt was made to develop a floating tablet using hydroxypropyl methylcellulose-90SH 15000 (HPMC-90SH 15000), microcrystalline cellulose, sodium bicarbonate, talc and lactose using direct compression method. The pa...
#1Ana Luísa G. Silva (UnB: University of Brasília)H-Index: 1
#2Natália V. Carvalho (UnB: University of Brasília)
Last. Sônia Nair Báo (UnB: University of Brasília)H-Index: 41
view all 7 authors...
Cancer constitutes group of diseases responsible for the second largest cause of global death, and it is currently considered one of the main public health concerns nowadays. Early diagnosis associated with the best choice of therapeutic strategy, is essential to achieve success in cancer treatment. In women, breast cancer is the second most common type, whereas ovarian cancer has the highest lethality when compared to other neoplasms of the female genital system. The present work, therefore, pr...
#1A. Taherian (Shahid Beheshti University)
#2Neda Esfandiari (Shahid Beheshti University)H-Index: 5
view all 3 authors...
Breast cancer is one of the most challenging cancers among women which is considered one of the most lethal cancers to this date. From the time that cancer has been discovered, finding the best therapeutic method is still an ongoing process. As a novel therapeutic method, nanomedicine has brought a vast number of materials that could versatilely be used as a drug carrier. The purpose of this study is to develop a novel black pomegranate peel extract loaded with chitosan-coated magnetic nanoparti...
#1Zehua Zhang (Third Military Medical University)H-Index: 15
#2Fei Dai (Third Military Medical University)H-Index: 10
Last. Lei Song (Third Military Medical University)H-Index: 15
view all 9 authors...
Osteosarcoma is a malignant osteoblastic tumor that can gravely endanger the lives and health of children and adolescents. Therefore, there is an urgent need to explore new biomarkers for osteosarcoma and determine new targeted therapies to improve the efficacy of osteosarcoma treatment. Diaphanous related formin 3 (DIAPH3) promotes tumorigenesis in hepatocellular carcinoma and lung adenocarcinoma, suggesting that DIAPH3 may be a target for tumor therapy. To date, there have been no reports on t...
Abstract null null Background null Ferroptosis is a form of programmed cell death that is closely associated with the development of various tumors. However, the correlation between ferroptosis and papillary thyroid carcinoma (PTC) is unclear. This study was performed to investigate the expression and prognostic value of ferroptosis-related genes (FRG) in PTC. null null null Methods null mRNA expression profiles and corresponding clinical data of patients with PTC were analyzed to identify facto...
#1Jiyue Ge (Bengbu Medical College)H-Index: 2
#2Likai Mao (Bengbu Medical College)H-Index: 2
Last. Chao Guan (Bengbu Medical College)H-Index: 3
view all 9 authors...
AbstractGrowing evidence points at an association between microRNAs and tumor development. Although dysregulation of microRNA-103a-3p (miR-103a-3p) in multiple human cancers has been reported, its ...
6 CitationsSource
#1Fardous F. El-Senduny (Mansoura University)H-Index: 10
#2Miram Altouhamy (Mansoura University)
Last. Farid A. Badria (Mansoura University)H-Index: 33
view all 10 authors...
Abstract null null Triple negative breast cancer (TNBC) is the most aggressive subtype of the breast cancer commonly occurring in females. It was estimated that around 17%–25% of people with breast cancer are triple negative. Despite the availability of various therapeutics and approaches for breast cancer treatment, there is still an increasing need to develop safe and efficacious agents for cancer therapy. Azadiradione (AZD), a bioactive agent isolated from Azadiractaindica, is known to posses...